Humacyte HUMA
NASDAQ HUMA
$0.51 -0.02 (-3.93%)
As of: Sep 30, 2026 · 3:16 PM EDT

Humacyte (HUMA) Revenue (2020 - 2026)

Updated

Humacyte (HUMA) posted Revenue of $406,000 for Q2 2026, up 34.9% from $301,000 a year earlier but down 18.0% from the prior quarter.

Analysis

Humacyte (HUMA) Revenue (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Humacyte was $2.12 million, up 159.3% year-over-year; for FY2025, it came in at $2.04 million.

  • Quarterly Revenue has run from a low of $241,000 in Q3 2021 to a high of $753,000 in Q3 2025 over five years.
  • According to Business Quant data, Revenue for the three prior quarters was $495,000 (Q1 2026), $467,000 (Q4 2025) and $753,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Humacyte 147.23 Mn 147.23 Mn -825,000.00 406,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 406,000.00
Mar 31, 2026 495,000.00
Dec 31, 2025 467,000.00
Sep 30, 2025 753,000.00
Jun 30, 2025 301,000.00
Mar 31, 2025 517,000.00
Sep 30, 2021 241,000.00
Sep 30, 2020 914,000.00
API Access

Humacyte Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=HUMA&period=max&api_key=YOUR_API_KEY